Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04978 |
| Species: | Homo sapiens |
| Position : | chr17:2261913-2262186 |
| Year: | 2015 |
| Title: | SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 25628225 |
| Tissue: | liver |
| Tissue Ontology ID: | UBERON:0002107 |
| Cell Source: | Hep-G2 |
| CVCL ID: | CVCL_0027 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay |
| Low Throughput Method: | Luciferase Reporter Assay; EMSA; ChIP; Reporter assay |
| Target gene : | SLC13A5 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|